All Pharma News
Merck, Ridgeback withdraw COVID drug application in EU

Merck, Ridgeback withdraw COVID drug application in EU
REUTERS
27 Jun 2023
Share Share
Merck and Ridgeback Provide Update on EU MAA for LAGEVRIO

Merck and Ridgeback Provide Update on EU MAA for LAGEVRIO
BUSINESSWIRE
24 Feb 2023
Share Share
NICE recommends against NHS use of 5 COVID treatments as not cost-effective

NICE recommends against NHS use of 5 COVID treatments as not cost-effective
REUTERS
17 Nov 2022
Share Share
Merck & Ridgeback Provide Update on Clinical & Non-Clinical Studies of LAGEVRIO

Merck & Ridgeback Provide Update on Clinical & Non-Clinical Studies of LAGEVRIO
BUSINESSWIRE
06 Oct 2022
Share Share
Emergent nets another manufacturing deal, for Ridgeback`s Ebola treatment

Emergent nets another manufacturing deal, for Ridgeback`s Ebola treatment
Tyler Patchen ENDPTS
11 Jul 2022
Share Share
Merck and Ridgeback Announce New Data For LAGEVRIO From PIII MOVe-OUT Study

Merck and Ridgeback Announce New Data For LAGEVRIO From PIII MOVe-OUT Study
BUSINESSWIRE
07 Jun 2022
Share Share
ICER`s latest cost analysis favors Paxlovid over molnupiravir

ICER`s latest cost analysis favors Paxlovid over molnupiravir
F. Kansteiner FIERCEPHARMA
11 May 2022
Share Share
Merck sold $3.2B worth Molnupiravir, driving first-quarter revenue growth

Merck sold $3.2B worth Molnupiravir, driving first-quarter revenue growth
S. Kimball CNBC
29 Apr 2022
Share Share
Pfizer`s Paxlovid to be on tap for thousands more in the U.K.

Pfizer`s Paxlovid to be on tap for thousands more in the U.K.
F. Kansteiner FIERCEPHARMA
13 Apr 2022
Share Share
Pfizer`s Paxlovid to be on tap for thousands more in the U.K.

Pfizer`s Paxlovid to be on tap for thousands more in the U.K.
Fraiser Kansteiner FIERCEPHARMA
12 Apr 2022
Share Share